메뉴 건너뛰기




Volumn 10, Issue 4, 2010, Pages 521-527

Chemotherapy-associated hepatotoxicity: How concerned should we be?

Author keywords

Colorectal carcinoma; Liver injury; Liver metastases; Neoadjuvant chemotherapy; Sinusoidal injury

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CISPLATIN; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

EID: 77951229582     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.09.185     Document Type: Review
Times cited : (13)

References (39)
  • 1
    • 2442704240 scopus 로고    scopus 로고
    • Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
    • Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann. Surg. 239(6), 818-825 (2004).
    • (2004) Ann. Surg. , vol.239 , Issue.6 , pp. 818-825
    • Abdalla, E.K.1    Vauthey, J.N.2    Ellis, L.M.3
  • 2
    • 0036104072 scopus 로고    scopus 로고
    • Trends in long-term survival following liver resection for hepatic colorectal metastases
    • Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg. 235(6), 759-766 (2002).
    • (2002) Ann. Surg. , vol.235 , Issue.6 , pp. 759-766
    • Choti, M.A.1    Sitzmann, J.V.2    Tiburi, M.F.3
  • 3
    • 4344615981 scopus 로고    scopus 로고
    • Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)
    • Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann. Surg. 240(3), 438-447 (2004).
    • (2004) Ann. Surg. , vol.240 , Issue.3 , pp. 438-447
    • Fernandez, F.G.1    Drebin, J.A.2    Linehan, D.C.3    Dehdashti, F.4    Siegel, B.A.5    Strasberg, S.M.6
  • 6
    • 0347481231 scopus 로고    scopus 로고
    • Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy
    • DOI 10.1016/j.gassur.2003.08.005
    • Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J. Gastrointest. Surg. 7(8), 1082-1088 (2003). (Pubitemid 37526731)
    • (2003) Journal of Gastrointestinal Surgery , vol.7 , Issue.8 , pp. 1082-1088
    • Parikh, A.A.1    Gentner, B.2    Wu, T.-T.3    Curley, S.A.4    Ellis, L.M.5    Vauthey, J.-N.6
  • 11
    • 34548513652 scopus 로고    scopus 로고
    • Final results of the EORTC Intergroup randomized Phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases
    • Nordlinger B, Sorbye H, Collette L et al. Final results of the EORTC Intergroup randomized Phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J. Clin. Oncol. 25, 18S (2007).
    • (2007) J. Clin. Oncol. , vol.25
    • Nordlinger, B.1    Sorbye, H.2    Collette, L.3
  • 12
    • 67650970110 scopus 로고    scopus 로고
    • The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: More is not always better
    • Karakousis G, Fong Y. The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: more is not always better. Ann. Surg. Oncol. 16(8), 2086-2088 (2009).
    • (2009) Ann. Surg. Oncol. , vol.16 , Issue.8 , pp. 2086-2088
    • Karakousis, G.1    Fong, Y.2
  • 14
    • 0036257307 scopus 로고    scopus 로고
    • Biochemical and cellular mechanisms of toxic liver injury
    • DOI 10.1055/s-2002-30100
    • Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Semin. Liver Dis. 22(2), 137-144 (2002). (Pubitemid 34496467)
    • (2002) Seminars in Liver Disease , vol.22 , Issue.2 , pp. 137-144
    • Kaplowitz, N.1
  • 15
    • 28844459409 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis: From cell biology to clinical practice
    • DOI 10.1016/j.jhep.2005.09.002, PII S0168827805006100
    • Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol. 44(1), 197-208 (2006). (Pubitemid 41772535)
    • (2006) Journal of Hepatology , vol.44 , Issue.1 , pp. 197-208
    • Cortez-Pinto, H.1    De Moura, M.C.2    Day, C.P.3
  • 16
    • 0036125693 scopus 로고    scopus 로고
    • Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease)
    • DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 22(1), 27-42 (2002).
    • (2002) Semin. Liver Dis. , vol.22 , Issue.1 , pp. 27-42
    • Deleve, L.D.1    Shulman, H.M.2    McDonald, G.B.3
  • 18
    • 32844458032 scopus 로고    scopus 로고
    • Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
    • DOI 10.1016/j.mito.2005.10.004, PII S1567724905001364
    • Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6(1), 1-28 (2006). (Pubitemid 43250588)
    • (2006) Mitochondrion , vol.6 , Issue.1 , pp. 1-38
    • Begriche, K.1    Igoudjil, A.2    Pessayre, D.3    Fromenty, B.4
  • 19
    • 63149185244 scopus 로고    scopus 로고
    • Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: Prevention by thiol group protecting agents
    • Custodio JB, Cardoso CM, Santos MS, Almeida LM, Vicente JA, Fernandes MA. Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents. Toxicology 259(1-2), 18-24 (2009).
    • (2009) Toxicology , vol.259 , Issue.1-2 , pp. 18-24
    • Custodio, J.B.1    Cardoso, C.M.2    Santos, M.S.3    Almeida, L.M.4    Vicente, J.A.5    Fernandes, M.A.6
  • 20
    • 29244492044 scopus 로고    scopus 로고
    • Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases [1]
    • DOI 10.1016/j.jamcollsurg.2005.09.010, PII S1072751505014407
    • Rubbia-Brandt L, Mentha G, Terris B. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J. Am. Coll. Surg. 202(1), 199-200 (2006). (Pubitemid 41831492)
    • (2006) Journal of the American College of Surgeons , vol.202 , Issue.1 , pp. 199-200
    • Rubbia-Brandt, L.1    Mentha, G.2    Terris, B.3
  • 21
    • 19744365905 scopus 로고    scopus 로고
    • Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
    • DOI 10.1016/j.jamcollsurg.2005.01.024, PII S1072751505001195
    • Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J. Am. Coll. Surg. 200(6), 845-853 (2005). (Pubitemid 40744790)
    • (2005) Journal of the American College of Surgeons , vol.200 , Issue.6 , pp. 845-853
    • Fernandez, F.G.1    Ritter, J.2    Goodwin, J.W.3    Linehan, D.C.4    Hawkins, W.G.5    Strasberg, S.M.6
  • 24
    • 14644399212 scopus 로고    scopus 로고
    • Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: A real entity (multiple letters) [1]
    • DOI 10.1093/annonc/mdi040
    • Sebagh M, Plasse M, Levi F, Adam R. Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity? Ann. Oncol. 16(2), 331 (2005). (Pubitemid 40309318)
    • (2005) Annals of Oncology , vol.16 , Issue.2 , pp. 331-333
    • Sebagh, M.1    Plasse, M.2    Levi, F.3    Adam, R.4    Rubbia-Brandt, L.5    Mentha, G.6    Dousset, B.7    Terris, B.8
  • 25
    • 37549068554 scopus 로고    scopus 로고
    • Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy
    • Nakano H, Oussoultzoglou E, Rosso E et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann. Surg. 247(1), 118-124 (2008).
    • (2008) Ann. Surg. , vol.247 , Issue.1 , pp. 118-124
    • Nakano, H.1    Oussoultzoglou, E.2    Rosso, E.3
  • 26
    • 58949094415 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management
    • Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49(1), 306-317 (2009).
    • (2009) Hepatology , vol.49 , Issue.1 , pp. 306-317
    • Vuppalanchi, R.1    Chalasani, N.2
  • 28
    • 34347234594 scopus 로고    scopus 로고
    • Preoperative chemotherapy for colorectal liver metastases: Impact on hepatic histology and postoperative outcome
    • Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J. Gastrointest. Surg. 11(7), 860-868 (2007).
    • (2007) J. Gastrointest. Surg. , vol.11 , Issue.7 , pp. 860-868
    • Pawlik, T.M.1    Olino, K.2    Gleisner, A.L.3    Torbenson, M.4    Schulick, R.5    Choti, M.A.6
  • 29
    • 37048998995 scopus 로고    scopus 로고
    • Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases
    • DOI 10.1002/cncr.23099
    • Ribero D, Wang H, Donadon M et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 110(12), 2761-2767 (2007). (Pubitemid 350250347)
    • (2007) Cancer , vol.110 , Issue.12 , pp. 2761-2767
    • Ribero, D.1    Wang, H.2    Donadon, M.3    Zorzi, D.4    Thomas, M.B.5    Eng, C.6    Chang, D.Z.7    Curley, S.A.8    Abdalla, E.K.9    Ellis, L.M.10    Vauthey, J.-N.11
  • 30
    • 55949084563 scopus 로고    scopus 로고
    • Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases
    • Kesmodel SB, Ellis LM, Lin E et al. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J. Clin. Oncol. 26(32), 5254-5260 (2008).
    • (2008) J. Clin. Oncol. , vol.26 , Issue.32 , pp. 5254-5260
    • Kesmodel, S.B.1    Ellis, L.M.2    Lin, E.3
  • 33
    • 0031781467 scopus 로고    scopus 로고
    • Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer
    • Peppercorn PD, Reznek RH, Wilson P, Slevin ML, Gupta RK. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br. J. Cancer 77(11), 2008-2011 (1998). (Pubitemid 28254648)
    • (1998) British Journal of Cancer , vol.77 , Issue.11 , pp. 2008-2011
    • Peppercorn, P.D.1    Reznek, R.H.2    Wilson, P.3    Slevin, M.L.4    Gupta, R.K.5
  • 34
    • 30144440445 scopus 로고    scopus 로고
    • CASH (chemotherapy-associated steatohepatitis) costs
    • DOI 10.1097/01.sla.0000193599.57858.9b
    • Fong Y, Bentrem DJ. CASH (chemotherapy-associated steatohepatitis) costs. Ann. Surg. 243(1), 8-9 (2006). (Pubitemid 43054047)
    • (2006) Annals of Surgery , vol.243 , Issue.1 , pp. 8-9
    • Fong, Y.1    Bentrem, D.J.2
  • 36
    • 40549124674 scopus 로고    scopus 로고
    • The extract of Prunus persica flesh (PPFE) attenuates chemotherapy-induced hepatotoxicity in mice
    • DOI 10.1002/ptr.2296
    • Lee CK, Park KK, Hwang JK, Lee SK, Chung WY. The extract of Prunus persica flesh (PPFE) attenuates chemotherapy-induced hepatotoxicity in mice. Phytother. Res. 22(2), 223-227 (2008). (Pubitemid 351363242)
    • (2008) Phytotherapy Research , vol.22 , Issue.2 , pp. 223-227
    • Chang, K.L.1    Kwang, K.P.2    Jae, K.H.3    Sang, K.L.4    Won, Y.C.5
  • 37
    • 46749133563 scopus 로고    scopus 로고
    • The pericarp extract of Prunus persica attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in mice
    • DOI 10.1089/jmf.2007.545
    • Lee CK, Park KK, Hwang JK, Lee SK, Chung WY. The pericarp extract of Prunus persica attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in mice. J. Med. Food 11(2), 302-306 (2008). (Pubitemid 351948168)
    • (2008) Journal of Medicinal Food , vol.11 , Issue.2 , pp. 302-306
    • Lee, C.K.1    Park, K.-K.2    Hwang, J.-K.3    Lee, S.K.4    Chung, W.-Y.5
  • 38
    • 62349101530 scopus 로고    scopus 로고
    • Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases
    • Brouquet A, Benoist S, Julie C et al. Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 145(4), 362-371 (2009).
    • (2009) Surgery , vol.145 , Issue.4 , pp. 362-371
    • Brouquet, A.1    Benoist, S.2    Julie, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.